Linking Immune Activation and Parkinson's Disease.

Bloem, Bastiaan R; Brundin, Patrik; Harms, Ashley; Lindestam Arlehamn, Cecilia; Tan, Eng-King; Williams-Gray, Caroline H

Bloem, Bastiaan R; Brundin, Patrik; Harms, Ashley; Lindestam Arlehamn, Cecilia; Tan, Eng-King; Williams-Gray, Caroline H.

Affiliation

Bloem BR; Radboud University Nijmegen Medical Center, Donders Institute for Brain, Cognition and Behavior, Center of Expertise for Parkinson & Movement Disorders, Department of Neurology, Nijmegen, the Netherlands.
Brundin P; Pharma Research and Early Development (pRED), F. Hoffman-La Roche, Little Falls, NJ, USA.
Harms A; Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, UAB | The University of Alabama at Birmingham, Birmingham, AL, USA.
Lindestam Arlehamn C; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, USA.
Tan EK; Department of Neurology, National Neuroscience Institute, Duke NUS Medical School, Singapore, Singapore.
Williams-Gray CH; Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, Cambridge, UK.

J Parkinsons Dis ; 12(s1): S1-S3, 2022.

Article de En | MEDLINE | ID: mdl-36155531

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Parkinson Limites: Humans Langue: En Journal: J Parkinsons Dis Année: 2022 Type de document: Article Pays d'affiliation: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google